Moncef Slaoui is a former Pharma R&D head and chairman vaccines at GSK, chairman of the board at Galvani Bioelectronics, Partner at Medicxi Venture Capital
Quick Facts and Information on Moncef Slaoui
| Full Name | Moncef Slaoui |
| Birthday / Date of Birth | 27th July 1959 |
| Age | 60 |
| Birth Sign | Leo |
| Born Country | Morocco |
| Hometown | Agadir |
| Nationality | Belgian, American, Moroccan |
| Ethnicity | Multiracial |
| Profession | Researcher / Chairman of the board at Galvani Bioelectronics |
| Education (High School / College / University) | IMD Business School |
| Marital Status | Married |
| Wife/ Spouse / Partner | Kristen Belmonte Slaoui |
| Children (Son, Daughter) | One |
| Social Media | None |
| Net Worth | $3 Million |
| Height in Feet | 5 ft 7 in |
Moncef Slaoui Career
Dr. Slaoui is Chairman of the board of directors of Galvani Bioelectronics, a company launched in November 2016 that GSK jointly owns with Verily Life Sciences. He has advised the U.S. President’s Council of Advisors on Science and Technology. Also, Moncef Slaoui was a member of the Board of the Agency for Science, Technology, & Research until January 2011, the PhRMA Foundation Board from 2008 to 2016, and the Advisory Committee to the Director of the National Institutes of Health from 2011 to 2016.
Dr. Slaoui previously served on the board of directors of Intellia Therapeutics Inc. (Nasdaq: NTLA). He is also a former Professor of Immunology at the University of Mons, Belgium. Dr. Slaoui received a Ph.D. in Molecular Biology and Immunology from Université Libre de Bruxelles.
Moncef Slaoui Wife
Mr. Slauoi is married to his beautiful wife Kristen E. Belmonte for some time now and they together are parents to their son.
Kristen B. Slaoui, PhD is Vice President and Head of Business Development for GlaxoSmithKline’s (GSK) Pharmaceuticals Commercial Portfolio. She has spent nearly 20 years with GSK, first in the research labs, where her work in pulmonary disease resulted in the discovery of the long-acting muscarinic receptor antagonist in the approved medicines.
She holds multiple patents, has authored more than 40 original peer-reviewed publications, and she has had ongoing roles as a peer reviewer for a dozen established medical journals. Since joining GSK’s Business Development teams in 2006, she has held various roles of increasing seniority and has executed more than $30 billion worth of deals and acquisitions. Mr. Slaoui’s wife, Kristen earned Bachelor’s degrees in both Biology and Classical Studies from Gettysburg College. She earned her Ph.D. in Physiology from The Johns Hopkins Bloomberg School of Public Health and completed an NIH Post-Doctoral Fellowship at the University of Washington in Seattle, WA.
After her term in Seattle, she accepted a position in Respiratory Drug Discovery at GSK, but continued her commitment to academic research by spending over a decade as an adjunct assistant professor at her alma mater, The Johns Hopkins Bloomberg School of Public Health in Baltimore, MD.
